Kouya Yamaki Selected Research

Organic Chemicals (Chemicals, Organic)

1/2007	Effects of components derived from diesel exhaust particles on lung physiology related to antigen.
11/2004	Components of diesel exhaust particles differentially affect lung expression of cyclooxygenase-2 related to bacterial endotoxin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kouya Yamaki Research Topics

Disease

6	Anaphylaxis (Anaphylactic Shock) 01/2023 - 01/2014
5	Arthritis (Polyarthritis) 03/2009 - 08/2003
5	Acute Lung Injury 03/2005 - 11/2003
2	Immune System Diseases (Immune Disorders) 01/2016 - 10/2014
2	Leukemia 04/2015 - 03/2010
2	Asthma (Bronchial Asthma) 09/2007 - 01/2007
2	Inflammation (Inflammations) 07/2004 - 12/2003
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023
1	Skin Manifestations 01/2023
1	Lymphoma (Lymphomas) 02/2022
1	Hypothermia 01/2016
1	Hypersensitivity (Allergy) 04/2015
1	Diarrhea 02/2014
1	Food Hypersensitivity (Food Allergy) 02/2014
1	Hyperplasia 02/2014
1	Allergic Rhinitis 09/2007
1	Rheumatoid Arthritis 07/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2004
1	Body Weight (Weight, Body) 04/2004
1	Atherosclerosis 04/2004
1	Pulmonary Edema 11/2003
1	Pneumonia (Pneumonitis) 11/2003

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 01/2023 - 08/2003
6	Immunoglobulin G (IgG)IBA 01/2023 - 08/2003
5	OvalbuminIBA 10/2023 - 01/2014
5	Immunoglobulin A (IgA)IBA 02/2022 - 01/2014
5	Immunoglobulin E (IgE)IBA 01/2016 - 01/2014
5	LipopolysaccharidesIBA 03/2005 - 11/2003
3	AntibodiesIBA 10/2023 - 03/2009
3	CytokinesIBA 04/2015 - 11/2004
3	Vehicle Emissions (Emissions, Vehicle)IBA 01/2007 - 11/2004
3	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2007 - 11/2004
2	AllergensIBA 10/2023 - 04/2015
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2023 - 01/2016
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 01/2016
2	EpitopesIBA 04/2015 - 03/2009
2	Interleukin-10 (Interleukin 10)IBA 02/2014 - 12/2003
2	RolipramIBA 01/2007 - 07/2004
2	Organic Chemicals (Chemicals, Organic)IBA 01/2007 - 11/2004
1	Imiquimod (Aldara)FDA LinkGeneric 10/2023
1	Platelet Activating FactorIBA 01/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023
1	Histamine H1 AntagonistsIBA 01/2016
1	fluorescein-ovalbuminIBA 01/2016
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2016
1	ruxolitinibIBA 02/2014
1	Janus Kinase InhibitorsIBA 02/2014
1	Interleukin-4 (Interleukin 4)IBA 02/2014
1	Interleukin-9 (Interleukin 9)IBA 02/2014
1	Interleukin-13IBA 02/2014
1	Janus KinasesIBA 02/2014
1	VaccinesIBA 01/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	perfluorooctanoic acidIBA 03/2010
1	perfluorooctaneIBA 03/2010
1	CollagenIBA 03/2009
1	Collagen Type II (Type II Collagen)IBA 03/2009
1	Indicators and Reagents (Reagents)IBA 03/2009
1	Butylated Hydroxytoluene (BHT)IBA 09/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2007
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2007
1	15-deoxyprostaglandin J2IBA 03/2005
1	Complementary DNA (cDNA)IBA 11/2004
1	Calcium-Binding ProteinsIBA 11/2004
1	Lipocalin-2IBA 11/2004
1	Triglycerides (Triacylglycerol)IBA 04/2004
1	Nitrogen DioxideIBA 04/2004
1	CholesterolIBA 04/2004
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2004
1	ChemokinesIBA 01/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2004
1	Indomethacin (Indometacin)FDA LinkGeneric 08/2003

Therapy/Procedure

2	Intravenous Injections 01/2016 - 04/2015
1	Intravenous Administration 01/2023
1	Oral Administration 02/2014